Pipeline | ImmuneMed

Pipeline

R&D Pipeline

R&D Pipeline 정보
Indication Discovery Preclinical Phase 1 Phase 2 Phase 3
Burfiralimab(IgG4)          
Chronic Hepatitis B        
Influenza-Induced Pneumonia        
Rheumatoid Arthritis        
IM-02(IgG1)          
Virus-Induced Cancer        
Small molecule *          
Viral Pneumonia(COVID-19)        
Oncology(PDAC)        
cGvHD        
IMV-01(Dengue Vaccine)        

* Collaboration with DGMIF